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of TPS. The collimator angle was changed from 0 to 170 degree, the 
leaf-speed was changed from 2.0 to 4.0 cm/sec. Then these plans 
were delivered to phantom and verified with three-dimensional 
detector: Delta4 (ScandiDos). All plans were delivered with a Varian 
Clinac 21EX linear accelerator equipped with Millenium multi-leaf 
collimator (MLC). The MLC motion logs during VMAT delivery were 
acquired and analyzed. The dose distributions were evaluated if those 
plans were acceptable for RTOG0615 dose tolerance or not. 
Results: As results of the plan comparison with several collimator 
angle settings, a single arc plan with collimator angle of 45 degree 
was acceptable for RTOG0615. On the other hand, all double arc plans 
were acceptable for RTOG0615. As results of the dosimetric 
verification by use of Delta4 detector, the passing rate of gamma 
analysis for the double arc plan with collimator angle 15/345 degree 
was worst in all plans. As results of comparison with various leaf-
speeds, the passing rates of gamma analysis were worse in plans with 
leaf-speed of more than 3.5 cm/sec.  
 
 Figure 1. The plan for dosimetric veification using Delta4 detector was 
created by Varian Eclipse TPS. 
Conclusions: The number of arc and maximum leaf-speed were 
affective factors for accurate dose delivery in VMAT plans. On the 
other hand, the setting of collimator angle was less affective 
parameter than those factors.  
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Purpose/Objective: The feasibility of using the Vero system for 
radiosurgery is yet unexplored. The high mechanical stability of the 
machine, the non-coplanar O-ring rotation liberty and the volumetric 
on-board imaging capabilities imply its use for intracranial 
stereotactic treatments. The Vero SBRT system was benchmarked in a 
planning study against a Novalis SRS system for quality of delivered 
dose distributions to intracranial lesions. 
Materials and Methods: A total of 27 patients with one single brain 
lesion treated on the BrainLAB Novalis system, with 3mm leaf width 
MLC and C-arm gantry, were re-planned for BrainLAB Vero, with a 
5mm leaf width MLC mounted on an O-ring gantry allowing rotations 
around both the horizontal and vertical axis. The Novalis dynamic 
conformal arc (DCA) planning included vertex arcs, using 90° couch 
rotation. These vertex arcs cannot be reproduced with Vero due to 
the mechanical limitations of the O-ring gantry. Alternative class 
solutions were investigated for the Vero (Figure 1). Additionally, to 
distinguish between the effect of MLC leaf width and different beam 
arrangements on dose distributions, the Vero class solutions were also 
applied for Novalis. The added value of IMRT was also investigated in 
this study. Quality of the achieved dose distributions was expressed in 
the conformity index (CI) and gradient index (GI), and compared using 
a paired Student t-test with statistical significance for p-values ≤ 
0.05.
 
Results: For the larger lesions, volumes > 5cm3 no statistical 
significant difference in conformity was observed between Vero and 
Novalis. For smaller lesions, the dose distributions showed a 
significantly better conformity for the Novalis (ΔCI=13.74%, p=0.0002) 
mainly due to the smaller MLC leaf width. IMRT on Vero reduces this 
conformity difference to non-significant levels compared to Novalis. 
The cut-off for realizing a GI of 3, characterizing a sharp dose fall-off 
outside the target volume was achieved for 4cm3 on Novalis and for 
7cm3 with the Vero using DCA technique. Using non-coplanar IMRT, 
this threshold was reduced to 3cm3 for the Vero system. 
Conclusions: The smaller MLC and the presence of the vertex fields 
allow the Novalis system to better conform the dose around the lesion 
and to obtain steeper dose fall-off outside the lesion. However, 
comparable dose dosimetric characteristics can be achieved on Vero 
for lesions larger then 3cm3 and using IMRT.  
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Purpose/Objective: When Elekta CMS XiO TPS was improved (v.4.62) 
with an additional segmentation method for IMRT planning, Smart 
Sequencing (SS), we realized that the shape and delivery sequence of 
the segments produce by this method were considerably different 
from the ones produced with the other available method, Sliding-
Window (SW). The purpose of this work was to study this new 
segmentation method by comparing the plans produced with this 
option (SS plans) to the one we had before (SW plans), for a group of 
selected prostate patients. We evaluated the impact both on the 
achieved dose distributions and QA results. 
Materials and Methods: We selected a group of IMRT prostate 
patients and evaluated 2 typical situations in our department: 
patients treating only prostate and seminal vesicles (Type 1) and 
patients treating also pelvic nodes (Type 2). We used the CMS XiO 
(v.4.62) TPS to calculate alternative IMRT plans (SW vs. SS), both 
calculated using the same dose constraints for target volumes and 
organs at risk and distribution of fields. The plans were produced to 
be delivered in Siemens PRIMUS linear accelerator with 6 or 18 MV 
beams. The plans were compared analysing DVH for the target and 
organs at risks, according to ICRU 83 recommendations. The impact on 
IMRT QA was evaluated comparing point dose measurements, with an 
ion chamber, and plane dose distributions, using a 2D array. We 
compared measured vs. calculated dose to a point in the phantom, 
and gamma parameters such as mean gamma value and gamma 
passing rate. 
Results: For Type 1 cases, we were able to produce plans with 
equivalent dose distributions to PTV and OARs using both 
segmentation methods but, for all cases, using de SS method resulted 
in plans with a reduced number of segments and MUs, and thus 
reduced delivery times. The QA results were considered equivalent 
and all patients were treated with the plans produced with the SS 
methods manly because of the reduced delivery time. 
For Type 2 cases, although SS plans resulted in a reduced number of 
segments and MUs, the SW plans always resulted in better dose 
distributions, namely in terms of OARs sparing. All patients were 
treated with these plans. No significant differences were found in 
terms of IMRT QA. 
Conclusions: When treating regular target volumes, such as most 
prostate tumours (Type 1), the use of Smart Sequencing (SS) 
segmentation method resulted in dose distributions equivalent or 
better than those achieved with the Sliding Window (SW) method, 
always with reduced number of segments and MU. The associated 
reduction in the delivery time will eventually allow us to treat more 
prostate patients with IMRT. 
